MAVERICK CAPITAL LTD - 31 Dec 2024 SCHEDULE 13G/A Report for Wave Life Sciences Ltd. $0 Par Value Ordinary Shares (WVE)

Filing Manager
MAVERICK CAPITAL LTD
Reporting Manager
Maverick Capital, Ltd.
Security
Wave Life Sciences Ltd. $0 Par Value Ordinary Shares
Symbol
WVE
Shares outstanding
152,985,963 shares
Disclosed Ownership
8,261,242 shares
Ownership
5.4%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:15:03 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"MAVERICK CAPITAL LTD disclosed 5.4% ownership in Wave Life Sciences Ltd. $0 Par Value Ordinary Shares (WVE) on 31 Dec 2024."

Quick Takeaways

  • MAVERICK CAPITAL LTD filed SCHEDULE 13G/A for Wave Life Sciences Ltd. $0 Par Value Ordinary Shares (WVE).
  • Disclosed ownership: 5.4%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Maverick Capital, Ltd. 5.4% 8,261,242 0 8,261,242 /s/ Trevor Wiessmann* By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager
Maverick Capital Management, LLC 5.4% 8,261,242 0 8,261,242 /S/ Trevor Wiessmann* Lee S. Ainslie III, Manager
Lee S. Ainslie III 5.4% 8,261,242 0 8,261,242 /S/ Trevor Wiessmann* Lee S. Ainslie III, Manager

Sponsored